Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vilain

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Oncotarget|October 25, 2016
PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trialsAngela M Hong, Ricardo E Vilain, Sarah Romanes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2015
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastasesHojabr Kakavand, Ricardo E Vilain, James S Wilmott, et al.
American Journal of Human Genetics|April 3, 2001
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humansB K Jordan, M Mohammed, S T Ching, et al.
Journal of the American Academy of Dermatology|November 5, 2019
The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort studyNorbertus A Ipenburg, Serigne N Lo, Ricardo E Vilain, et al.
International Journal of Dermatology|August 5, 2021
Confocal microscopy, dermoscopy, and histopathology features of atypical intraepidermal melanocytic proliferations associated with evolution to melanoma in situLilian K F L Rocha, Ricardo E Vilain, Richard A Scolyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Loss of sequences 3' to the testis-determining gene, SRY, including the Y pseudoautosomal boundary associated with partial testicular determinationK McElreavey, E Vilain, S Barbaux, et al.
The American Journal of Surgical Pathology|February 13, 2016
Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional InitiationKlaus J Busam, Ricardo E Vilain, Trina Lum, et al.
Cancer Research Communications|March 16, 2023
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 RechallengeAndre van der Westhuizen, Megan Lyle, Moira C Graves, et al.
Plos One|August 14, 2013
Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanomaNikola A Bowden, Katie A Ashton, Ricardo E Vilain, et al.
Pigment Cell & Melanoma Research|December 6, 2014
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trialsJason Madore, Ricardo E Vilain, Alexander M Menzies, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Oncotarget|October 25, 2016
PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trialsAngela M Hong, Ricardo E Vilain, Sarah Romanes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2015
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastasesHojabr Kakavand, Ricardo E Vilain, James S Wilmott, et al.
American Journal of Human Genetics|April 3, 2001
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humansB K Jordan, M Mohammed, S T Ching, et al.
Journal of the American Academy of Dermatology|November 5, 2019
The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort studyNorbertus A Ipenburg, Serigne N Lo, Ricardo E Vilain, et al.
International Journal of Dermatology|August 5, 2021
Confocal microscopy, dermoscopy, and histopathology features of atypical intraepidermal melanocytic proliferations associated with evolution to melanoma in situLilian K F L Rocha, Ricardo E Vilain, Richard A Scolyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Loss of sequences 3' to the testis-determining gene, SRY, including the Y pseudoautosomal boundary associated with partial testicular determinationK McElreavey, E Vilain, S Barbaux, et al.
The American Journal of Surgical Pathology|February 13, 2016
Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional InitiationKlaus J Busam, Ricardo E Vilain, Trina Lum, et al.
Cancer Research Communications|March 16, 2023
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 RechallengeAndre van der Westhuizen, Megan Lyle, Moira C Graves, et al.
Plos One|August 14, 2013
Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanomaNikola A Bowden, Katie A Ashton, Ricardo E Vilain, et al.
Pigment Cell & Melanoma Research|December 6, 2014
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trialsJason Madore, Ricardo E Vilain, Alexander M Menzies, et al.
Pageof 7